Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects

NCT01631864 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Concurrent Obesity

Interventions

DRUG: LCZ696
DRUG: amlodipine
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals